Study: Aspirin cuts death risk in prostate cancer patients

10/25/2010 | WebMD

Preliminary results from a large study show that anti-coagulants, particularly aspirin, reduced the risk of death by more than 50% for men with prostate cancer that had not spread beyond the gland. Patients who took anti-coagulants were also less likely to experience cancer recurrence than those who didn't take such drugs.

View Full Article in:

WebMD

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA